Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapy

N Okamoto, H Yotsuyanagi, S Ooka, T Matsui… - Intervirology, 2003 - karger.com
Objective: To understand the autoimmunity associated with chronic hepatitis C (CHC), we
investigated autoantibodies (autoAbs) to CD69. Methods: With this aim, we tested the …

Autoantibodies to CD69 in patients with chronic hepatitis type C: A candidate marker for predicting the response to interferon therapy

N Okamoto, H Yotsuyanagi, S Ooka, T Matsui - Intervirology, 2003 - search.proquest.com
Original Paper Page 1 Intervirology 2003;46:56—65 DOI: 10.1159/000068126 Original Paper
Received: October 6, 2002 Accepted after revision: October 12, 2002 Autoantibodies to CD69 in …

Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapy

N Okamoto, H Yotsuyanagi, S Ooka, T Matsui… - …, 2003 - pubmed.ncbi.nlm.nih.gov
Objective To understand the autoimmunity associated with chronic hepatitis C (CHC), we
investigated autoantibodies (autoAbs) to CD69. Methods With this aim, we tested the …

Autoantibodies to CD69 in Patients with Chronic Hepatitis Type C: A Candidate Marker for Predicting the Response to Interferon Therapy

N Okamoto, H Yotsuyanagi, S Ooka, T Matsui… - Intervirology, 2003 - karger.com
Objective: To understand the autoimmunity associated with chronic hepatitis C (CHC), we
investigated autoantibodies (autoAbs) to CD69. Methods: With this aim, we tested the …

Autoantibodies to CD69 in Patients with Chronic Hepatitis Type C: A Candidate Marker for Predicting the Response to Interferon Therapy.

N Okamoto, H Yotsuyanagi, S Ooka, T Matsui… - …, 2003 - search.ebscohost.com
AbstractObjective: To understand the autoimmunity associated with chronic hepatitis C
(CHC), we investigated autoantibodies (autoAbs) to CD69. Methods: With this aim, we tested …

Autoantibodies to CD69 in patients with chronic hepatitis type C: a candidate marker for predicting the response to interferon therapy.

N Okamoto, H Yotsuyanagi, S Ooka, T Matsui… - Intervirology, 2003 - europepmc.org
To understand the autoimmunity associated with chronic hepatitis C (CHC), we investigated
autoantibodies (autoAbs) to CD69. With this aim, we tested the reactivity of serum samples …

[引用][C] Autoantibodies to CD69 in patients with chronic hepatitis type C: A candidate marker for predicting the response to interferon therapy

N OKAMOTO, H YOTSUYANAGI, S OOKA, T MATSUI… - Intervirology, 2003 - Karger